Catastrophic expenditures in PCa survivors. From @BWHUrology @SUO_YUO fellow @benvstone
⬆️ catastrophic expenses w private insurance
⬆️ financial worry with younger age
Underscores the “perfect storm” of work disruptions + tying insurance to employment in younger cancer pts
Just wrapped up an amazing Urology Lab #AQUILON gathering at @AmerUrological#AUA23! Our powerhouse of researchers brings a unique perspective to the field.
🇺🇸 🇬🇧 🇩🇪 🇻🇳 🇮🇹 🇷🇴 🇮🇳 🇨🇦 🇱🇧 🇸🇦 🇮🇶 🇨🇳 🇫🇷 🇧🇷 🇲🇽 🇹🇼 🇸🇬 🇵🇰 🇰🇷
Our family keeps on growing everyday #UroSoMe ❤️
Please join for a Virtual Open House on Tuesday 12/20 from 8-9pm EST for the Combined Harvard Urologic Oncology Fellowship @MGHUrology @BWHUrology. Meet fellows, residents and faculty in an open setting https://t.co/LUGEZzTkKC
@SUO_YUO@UroOnc
Patients with adrenal cancer have improved survival at academic centers, with aggressive surgical treatment and multidisciplinary care.
Read the full text here: https://t.co/eJBots1FbZ @benvstone @Drkelvinmoses06
Patients with adrenal cancer have improved survival at academic centers, with aggressive surgical treatment and multidisciplinary care.
Read the full text here: https://t.co/eJBots1FbZ
@benvstone @Drkelvinmoses06
@syan_sumeet @Svet_MD There’s such a need for more work to be done to improve the survivorship experience across urologic malignancies. Thanks for the kind words, I’d always be interested in being involved!
@lillianylai@urogeek@DanBarocas@AmyLuckenbaugh@a_laviana Treatment non-adherence is reported broadly in cancer patients due to financial toxicity, but not well defined in the prostate cancer population. Certainly a lot of work to be done.
Visual abstract of our study on financial toxicity associated with prostate cancer treatment. Thankful to have such incredible research mentors @urogeek@DanBarocas@AmyLuckenbaugh@a_laviana